摘要
《中国脑血管病临床管理指南(第2版)》是中国卒中学会组织专家根据近年来脑血管病领域研究的新进展、获取的新证据,对2019年第1版《中国脑血管病临床管理指南》进行的修订、补充和完善。该版指南涵盖脑血管病的全方位临床管理,包括卒中的组织化管理、高危人群管理、缺血性和出血性卒中以及脑静脉系统血栓形成的临床管理、卒中的康复管理等,旨在为从事卒中防治、护理、康复的相关专业人员和社会工作者,以及政府部门相关管理机构、卫生事业管理人员、医药企业、卫生保健需求方和其他利益相关者提供指导意见。
The Second Edition of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases is an updated and enhanced version of the first edition,which was first published in 2019.This latest edition has been meticulously compiled by a panel of authoritative experts from the Chinese Stroke Association,incorporating recent breakthroughs and novel evidence within the field of cerebrovascular diseases.The guideline provides a comprehensive overview of clinical management strategies for cerebrovascular diseases,including structured stroke care,management of high-risk populations,therapeutic interventions for both ischemic and hemorrhagic strokes,clinical management of cerebral venous sinus thrombosis,and stroke rehabilitation management.The primary objective is to provide guidance for professionals and social workers engaged in stroke prevention,care,and rehabilitation,as well as governmental agencies,healthcare administrators,pharmaceutical companies,healthcare providers,and other stakeholders.
作者
谭泽锋
刘丽萍
徐安定
中国卒中学会中国脑血管病临床管理指南撰写工作委员会
TAN Zefeng;LIU Liping;XU Anding;the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases(Department of Neurology,the First People’s Hospital of Foshan,Foshan 528000,China;Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Neurology,the First Affiliated Hospital of Jinan University,Cerebrovascular Disease Center,the First Affiliated Hospital of Jinan University,Guangzhou 510632,China;不详)
出处
《中国卒中杂志》
2023年第7期817-821,共5页
Chinese Journal of Stroke
关键词
脑血管病
临床管理
指南
证据
推荐
Cerebrovascular disease
Clinical management
Guideline
Evidence
Recommendation
